NASDAQ NMS - GLOBAL MARKET · AEMD
-0.34% · -$0.0092 · Vol 37.5K
Market closed · last close 4:00 PM ET · price as of 19:41:50 ET
Aethlon Medical Inc

Aethlon Medical Inc

Health Care
$2.69
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
AEMD
Aethlon Medical Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

29/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AEMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AEMD catalysts
About Aethlon Medical Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
1998
Employees
9
Country
US

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.81
Day high
$2.82
Day low
$2.69
Previous close
$2.70
52W high
$102.00
-97.36% from high
52W low
$2.66
0% of range
Market cap
$1.9M
EPS
$-10.4100
Beta
2.00
Shares out
711.1K
Volume
37.5K
0.84× rel vol
Avg volume
44.4K
VWAP
$2.74
Price history computed in-house
1W
-8.32%
1M
-7.96%
3M
-78.03%
1Y
-96.62%
YTD
-80.57%
SMA 50 $4.24 · below
SMA 200 $10.95 · below
52W position 0%

AEMD overview

Veridion Score
29
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AEMD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AEMD Form 4 filings
Public disclosures

Congress activity in AEMD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AEMD in the cached public ledger.

Federal contracts

AEMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AEMD in this window.
Lobbying spend

AEMD lobbying filings, year to date.

Registered lobbying filings matched to Aethlon Medical Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AEMD in this window.
Loading news for AEMD
Analyst ratings
Sovereign unlock shows live analyst consensus for AEMD.
Options
Sovereign unlock shows live options positioning for AEMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.